{ "items": [ "\n\n
\n \n Journal article\n \n
\n \n\n \n \n \nQu\u00e9r\u00e9e P. et al, (2009), Br J Pharmacol, 158, 1477 - 1485
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nTemel Y. et al, (2009), Brain, 132
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nElizalde N. et al, (2009), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 19, S227 - S227
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nSharp T. et al, (2009), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 19, S177 - S177
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nWalton ME. et al, (2009), Eur J Neurosci, 29, 1678 - 1691
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nPreece MA. et al, (2009), Neuroscience, 159, 751 - 759
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nPringle A. et al, (2008), Psychopharmacology (Berl), 200, 291 - 300
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDekeyne A. et al, (2008), Psychopharmacology (Berl), 199, 549 - 568
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nJennings K. et al, (2008), FUNDAMENTAL & CLINICAL PHARMACOLOGY, 22, 128 - 128
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSharp T. et al, (2008), FUNDAMENTAL & CLINICAL PHARMACOLOGY, 22, 115 - 115
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nKaya AH. et al, (2008), Brain Res, 1221, 93 - 97
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nJennings KA. et al, (2008), Neuropharmacology, 54, 776 - 783
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSharp T. et al, (2007), Trends Pharmacol Sci, 28, 629 - 636
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nPreece MA. et al, (2007), Synapse, 61, 925 - 932
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nTemel Y. et al, (2007), Proc Natl Acad Sci U S A, 104, 17087 - 17092
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nHughes ZA. et al, (2007), Psychopharmacology (Berl), 192, 121 - 133
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nStark AD. et al, (2007), Psychopharmacology (Berl), 190, 373 - 382
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nHaj\u00f3s M. et al, (2007), Eur J Neurosci, 25, 119 - 126
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSharp T. and Zetterstr\u00f6m T., (2006), Handbook of Behavioral Neuroscience, 16, 5 - 16
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBoothman L. et al, (2006), Br J Pharmacol, 149, 861 - 869
\n \n \n \n\n
\n \n \n \n